Esperion Therapeutics
ESPR
#6987
Rank
โ‚น36.68 B
Marketcap
โ‚น186.20
Share price
0.69%
Change (1 day)
-5.14%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น58.18 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are โ‚น58.18 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น55.01 B16.28%
2022-12-31โ‚น47.30 B9.87%
2021-12-31โ‚น43.06 B31.02%
2020-12-31โ‚น32.86 B136.96%
2019-12-31โ‚น13.86 B208.33%
2018-12-31โ‚น4.49 B112.56%
2017-12-31โ‚น2.11 B87.48%
2016-12-31โ‚น1.12 B104.33%
2015-12-31โ‚น0.55 B-10.34%
2014-12-31โ‚น0.61 B137.29%
2013-12-31โ‚น0.25 B-80.8%
2012-12-31โ‚น1.35 B210.41%
2011-12-31โ‚น0.43 B
2002-12-31โ‚น0.60 B6.28%
2001-12-31โ‚น0.57 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น100.71 B 73.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น122.24 B 110.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.791 T 18,446.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น690.05 B 1,085.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น51.67 B-11.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น12.12 B-79.16%๐Ÿ‡บ๐Ÿ‡ธ USA